PHAT vs TECH
Phathom Pharmaceuticals Inc (PHAT) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Phathom Pharmaceuticals Inc (PHAT) is a biotechnology company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported PHAT revenue for 2024-12-31 was $55.3M. Net income was -$334.3M. Revenue was up 8001.5% from 2023-12-31 to 2024-12-31. PHAT currently screens at market cap $622.7M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
PHAT currently screens at market cap $622.7M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the PHAT and TECH stock pages for the full models.
Not investment advice.